IBDEI3I3 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,499,0)
 ;;=PERITONEAL DIALYSIS ENCOUNTER^22^52
 ;;^UTILITY(U,$J,358.4,500,0)
 ;;=CARDIOLOGY/CARDIORENAL SYNDROME^2^52
 ;;^UTILITY(U,$J,358.4,501,0)
 ;;=COMPLICATIONS/OTHER^4^52
 ;;^UTILITY(U,$J,358.4,502,0)
 ;;=CYSTIC KIDNEY DISEASE^5^52
 ;;^UTILITY(U,$J,358.4,503,0)
 ;;=DIABETES/DIABETIC RENAL DISEASE^6^52
 ;;^UTILITY(U,$J,358.4,504,0)
 ;;=FLUID/ELECTROLYTE DISORDER^7^52
 ;;^UTILITY(U,$J,358.4,505,0)
 ;;=GENERAL SYMPTOMS^8^52
 ;;^UTILITY(U,$J,358.4,506,0)
 ;;=GENITAL/URINARY^9^52
 ;;^UTILITY(U,$J,358.4,507,0)
 ;;=HEMATOLOGY^11^52
 ;;^UTILITY(U,$J,358.4,508,0)
 ;;=HYPERTENSION^14^52
 ;;^UTILITY(U,$J,358.4,509,0)
 ;;=INFECTIOUS DISEASE^15^52
 ;;^UTILITY(U,$J,358.4,510,0)
 ;;=NEPHRITIS GLUMERULONEPHRITIS^17^52
 ;;^UTILITY(U,$J,358.4,511,0)
 ;;=NEPHRITIS INTERSTITIAL^18^52
 ;;^UTILITY(U,$J,358.4,512,0)
 ;;=NEPHROTIC SYNDROME^20^52
 ;;^UTILITY(U,$J,358.4,513,0)
 ;;=OBSTRUCTIVE UROPATHY^21^52
 ;;^UTILITY(U,$J,358.4,514,0)
 ;;=TRANSPLANT^24^52
 ;;^UTILITY(U,$J,358.4,515,0)
 ;;=CKD/KIDNEY DISEASE^3^52
 ;;^UTILITY(U,$J,358.4,516,0)
 ;;=HEMODIALYSIS-AKI^12^52
 ;;^UTILITY(U,$J,358.4,517,0)
 ;;=ACUTE KIDNEY INJURY^1^52
 ;;^UTILITY(U,$J,358.4,518,0)
 ;;=GLOMERULAR DISEASE^10^52
 ;;^UTILITY(U,$J,358.4,519,0)
 ;;=KIDNEY INVOLVMNT IN SYSTEMIC DISEASE^16^52
 ;;^UTILITY(U,$J,358.4,520,0)
 ;;=NEPHROLITHASIS^19^52
 ;;^UTILITY(U,$J,358.4,521,0)
 ;;=POISONING & INTOXICATIONS^23^52
 ;;^UTILITY(U,$J,358.4,522,0)
 ;;=CLINICIAN^1^53
 ;;^UTILITY(U,$J,358.4,523,0)
 ;;=PHARMACISTS^1^54
 ;;^UTILITY(U,$J,358.4,524,0)
 ;;=PHYSICAL THERAPISTS^2^54
 ;;^UTILITY(U,$J,358.4,525,0)
 ;;=RADIOLOGIST^4^54
 ;;^UTILITY(U,$J,358.4,526,0)
 ;;=PSYCHOLOGISTS^3^54
 ;;^UTILITY(U,$J,358.4,527,0)
 ;;=ACUTE RENAL FAILURE^1^55
 ;;^UTILITY(U,$J,358.4,528,0)
 ;;=CARDIOVASCULAR^2^55
 ;;^UTILITY(U,$J,358.4,529,0)
 ;;=CHRONIC KIDNEY DISEASE^3^55
 ;;^UTILITY(U,$J,358.4,530,0)
 ;;=CONTACT/EXPOSURE TO COM D^4^55
 ;;^UTILITY(U,$J,358.4,531,0)
 ;;=DERMATOLOGY^5^55
 ;;^UTILITY(U,$J,358.4,532,0)
 ;;=DIABETES W/ COMPLICATIONS^6^55
 ;;^UTILITY(U,$J,358.4,533,0)
 ;;=DIABETES W/O COMPLICATION^7^55
 ;;^UTILITY(U,$J,358.4,534,0)
 ;;=EENT^8^55
 ;;^UTILITY(U,$J,358.4,535,0)
 ;;=ENDOCRINE/METABOLIC^9^55
 ;;^UTILITY(U,$J,358.4,536,0)
 ;;=GASTROENTEROLOGY^10^55
 ;;^UTILITY(U,$J,358.4,537,0)
 ;;=GENITOURINARY^11^55
 ;;^UTILITY(U,$J,358.4,538,0)
 ;;=HEMATOLOGY/ONCOLOGY^12^55
 ;;^UTILITY(U,$J,358.4,539,0)
 ;;=HISTORY & STATUS POST^13^55
 ;;^UTILITY(U,$J,358.4,540,0)
 ;;=INFECTIOUS DISEASE^14^55
 ;;^UTILITY(U,$J,358.4,541,0)
 ;;=INFLAMMATORY/INF LUNG DX^15^55
 ;;^UTILITY(U,$J,358.4,542,0)
 ;;=INTERSTITIAL DISEASE^16^55
 ;;^UTILITY(U,$J,358.4,543,0)
 ;;=MENTAL HEALTH^17^55
 ;;^UTILITY(U,$J,358.4,544,0)
 ;;=MUSCULOSKELETAL^18^55
 ;;^UTILITY(U,$J,358.4,545,0)
 ;;=NEUROLOGY^19^55
 ;;^UTILITY(U,$J,358.4,546,0)
 ;;=OBSTRUCTIVE AIRWAY DISEASE^20^55
 ;;^UTILITY(U,$J,358.4,547,0)
 ;;=ORAL CAVITY^21^55
 ;;^UTILITY(U,$J,358.4,548,0)
 ;;=OTHER REASONS^22^55
 ;;^UTILITY(U,$J,358.4,549,0)
 ;;=PAIN^23^55
 ;;^UTILITY(U,$J,358.4,550,0)
 ;;=PERSONAL HX OF CANCER^24^55
 ;;^UTILITY(U,$J,358.4,551,0)
 ;;=PLEURAL DISEASE^25^55
 ;;^UTILITY(U,$J,358.4,552,0)
 ;;=PNEUMONIA^26^55
 ;;^UTILITY(U,$J,358.4,553,0)
 ;;=PULMONARY VASCULAR DISEASE^27^55
 ;;^UTILITY(U,$J,358.4,554,0)
 ;;=RESPIRATORY^28^55
 ;;^UTILITY(U,$J,358.4,555,0)
 ;;=SECONDARY DIABETES^29^55
 ;;^UTILITY(U,$J,358.4,556,0)
 ;;=SIGNS, SYMPTOMS, CONDITIONS^30^55
 ;;^UTILITY(U,$J,358.4,557,0)
 ;;=SLEEP DISORDERS^31^55
 ;;^UTILITY(U,$J,358.4,558,0)
 ;;=THROMBO EMBOLIC DISEASE^32^55
 ;;^UTILITY(U,$J,358.4,559,0)
 ;;=TUMOR^33^55
